Get the Stockscreener App
1.25
0.79%
-0.01
Oragenics Inc stock is traded at $1.25, with a volume of 107.75K.
It is down -0.79% in the last 24 hours and down -19.35% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$1.26
Open:
$1.24
24h Volume:
107.75K
Relative Volume:
0.18
Market Cap:
$1.04M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1464
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
-10.07%
1M Performance:
-19.35%
6M Performance:
-86.52%
1Y Performance:
-95.87%
1-Day Range:
$1.23
$1.29
1-Week Range:
$1.23
$1.42
52-Week Range:
$1.23
$75.60
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
1.25 | 1.04M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Stock (OGEN) Latest News
Will Oragenics Inc. outperform the marketPattern Recognition Tool for ROI Investors - Newser
Quantitative breakdown of Oragenics Inc. recent moveBuy List With Technical Entry Triggers - Newser
Oragenics Inc. stock trend forecastStrategy Chart for Real-Time Trade Flow - Newser
Real time breakdown of Oragenics Inc. stock performanceSmart Trade Forecast Based on Neural Logic - Newser
What makes Oragenics Inc. stock price move sharplyEarly Entry Planner for Swing Candidates - Newser
What institutional investors are buying Oragenics Inc. stockAI Powered Target Finder For Consistent Profits - jammulinksnews.com
Oragenics Announces Approval of Common Stock Listing on NYSE MKT - AOL.com
Is Oragenics Inc. stock overvalued or undervaluedValue Investing Opportunities For 2025 - jammulinksnews.com
Oragenics Inc. Shows Risk Reward Favoring UpsideStock Portfolio Allocation Guidance for Volatile Markets - metal.it
Published on: 2025-08-01 00:30:26 - Newser
Using Ichimoku Cloud for Oragenics Inc. technicalsDeep Stock Performance and Volatility Analysis - Newser
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial - GlobeNewswire
Evaluating Oragenics Inc. with trendline analysisShort-Term Sector Movement Forecast Generator - Newser
Is Oragenics Inc. stock poised for growthTechnical Setup and Return Forecast Engine - Newser
Chart based analysis of Oragenics Inc. trendsFree Consistent Gain Investment Strategies - Newser
Smart tools for monitoring Oragenics Inc.’s price actionSwing Gain Strategy with Entry Forecast - Newser
Is Oragenics Inc. forming a bottoming baseMulti-Year Investment Performance Summary Report - Newser
Sector Rotation Brings Oragenics Inc. Into FocusCapital Efficiency Optimized Stock Alerts Reviewed - metal.it
Can momentum traders help lift Oragenics Inc.Profitable Trading Blueprint with Entry Zones - Newser
How Oragenics Inc. stock performs during market volatilityChart Pattern Strategy with ROI Focus - Newser
Fibonacci Levels Suggest Recovery for Oragenics Inc.Wealth Building Stock Market Ideas Based on Momentum - metal.it
How many analysts rate Oragenics Inc. as a “Buy”Post Market Growth Plan With High Returns - jammulinksnews.com
What are the technical indicators suggesting about Oragenics Inc.Track top-performing stocks in real-time - jammulinksnews.com
Should I hold or sell Oragenics Inc. stock in 2025Capitalize on market momentum for maximum gains - jammulinksnews.com
What are the latest earnings results for Oragenics Inc.Consistently exceptional gains - jammulinksnews.com
How does Oragenics Inc. compare to its industry peersBuild a strong portfolio for long-term success - jammulinksnews.com
Will Oragenics Inc. Stock Benefit from AI and Green Energy TrendsShort Term High Return Strategy - Newser
Is Oragenics Inc. Stock a Good Fit for Conservative InvestorsBalanced Risk Reward Portfolio - Newser
Oragenics Inc. Stock Performance After Earnings: Historical InsightsSmart Growth Low Risk Picks - Newser
Why Oragenics Inc. stock attracts strong analyst attentionFree Investment Group - Newser
What drives Oragenics Inc. stock priceMarket-crushing profits - PrintWeekIndia
When is the best time to buy Oragenics Inc. stockExplosive market performance - jammulinksnews.com
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):